Inflammation of liver causes hepatitis. Hepatitis C is a contagious liver disease caused due to hepatitis C virus. Hepatitis C damages and infects the liver. Hepatitis C is spread as the infected blood comes in contact with non-infected blood. Ranging in severity hepatitis C can cause acute and chronic hepatitis infection. Chronic hepatitis C is diagnosed by liver biopsy and blood tests. According to World Health Organization (WHO), globally 130 million to 150 million people are suffering from chronic hepatitis C. Hepatitis C is treated with antiviral drugs to inhibit the growth of virus and prevent liver damage. According to World Health Organization (WHO), 50% to 90% of people suffering from hepatitis C are treated with antiviral treatment.
Get Sample Copy Of This @ https://www.persistencemarketresearch.com/samples/3379
North America dominates the global market for hepatitis C virus antiviral due to rising incidence of infectious diseases. Asia followed by the Europe are expected to show high growth rates in the next five years in global hepatitis C virus antiviral market. China and India are expected to be the fastest growing hepatitis C virus antiviral markets in Asia-Pacific region. Some of the key driving forces for hepatitis C virus antiviral market in emerging countries are large pool of patients, increasing awareness programs and rising government funding.
In recent times there is increased use of hepatitis C virus antiviral due to increasing incidence of chronic infection with hepatitis C virus. Increase in healthcare expenditure, changing lifestyle and increasing government initiatives are some of the key factors driving the growth for global hepatitis C virus antiviral market. In addition, increasing healthcare awareness is also fuelling the growth of global hepatitis C virus antiviral market. However, stringent regulation for approval of hepatitis C antiviral is the major factors restraining the growth for the global hepatitis C virus antiviral market.
Introduction of interferon-free oral therapies would develop opportunity for the global hepatitis C virus antiviral market. The trend for global hepatitis C virus antiviral market is rise in awareness programs and promoting partnerships by World Health Organization (WHO). Some of the major companies operating in the global hepatitis C virus antiviral market are Merck & Co., Genentech, Merck, Vertex, Janssen and Medivir AB, F. Hoffmann-La Roche, Bristol Myers Squibb, AbbVie and Gilead Sciences.
Request For TOC @ https://www.persistencemarketresearch.com/toc/3379
Key points covered in the report
- Report segments the market on the basis of types, application, products, technology, etc (as applicable)
- The report covers geographic segmentation
- North America
- Europe
- Asia
- RoW
- The report provides the market size and forecast for the different segments and geographies for the period of 2010 to 2020
- The report provides company profiles of some of the leading companies operating in the market
- The report also provides porters five forces analysis of the market.
